Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
NCT06203574

Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors

Led by Huashan Hospital · Updated on 2024-06-18

60

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will investigate the safety and preliminary diagnostic efficacy of \[68Ga\]Ga-NOTA-T4 or \[18F\]AlF-RESCA-T4 in pancreatic cancer, breast cancer, head and neck cancer, lung cancers and other types of solid tumors. Then, this study will provide a new method for the noninvasive target-specific diagnosis of pancreatic cancer, breast cancer, head and neck cancer, lung cancers and other types of solid tumors. PET imaging of TROP-2 will be integrated to TROP-2-targeted therapies in some of the included patients. Therefore, PET imaging with \[68Ga\]Ga-NOTA-T4 or \[18F\]AlF-RESCA-T4 will help select patients for targeted therapy and monitor treatment responses after the treatment.

CONDITIONS

Official Title

Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be between 18 and 65 years of age and of either sex.
  • Patients with colorectal cancer confirmed by puncture or surgical pathology.
  • Written informed consent signed by the subject or legal guardian or caregiver.
  • Willingness and ability to cooperate with all programs of this study.
Not Eligible

You will not qualify if you...

  • Severe hepatic or renal insufficiency.
  • Targeted therapy before radiotherapy or PET/CT scan.
  • Renal function: serum creatinine must be less than or equal to the upper limit of the normal range.
  • Liver function: bilirubin, AST (SGOT), and ALT (SGPT) must be less than or equal to the upper limit of the normal range.
  • History of serious surgery in the last month.
  • Participation in other clinical trials during the same period.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Huashan Hospital

Shanghai, China

Actively Recruiting

Loading map...

Research Team

Y

Yihui Guan, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here